| Today's Open | $9.52 |
|---|---|
| Previous Close | $9.47 |
| Daily Range | $9.42 - $10.81 |
| 52-Week Range | $4.96 - $10.81 |
| Market Cap | $386.2M |
| P/E Ratio | -189.40 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 904,735 |
| Average Daily Volume | 160,283 |
| Current FY EPS | $0.14 |
Sector
Healthcare
Industry
Healthcare Information Services
STAAR Surgical Company (STAA) Description
The Company develops and manufactures minimally invasive visual implants and other ophthalmic products to improve or correct the vision of patients with cataracts and refractive conditions and distributes them worldwide. Website: http://www.staar.com/
News & Commentary
STAAR Surgical Receives Regulatory Approvals for Visian ICL with CentraFLOW Technology in Korea, Arg
STAAR Surgical Receives Regulatory Approvals for Visian ICL with CentraFLOW Technology in Korea, ArgentinaThis Metric Suggests You're Right to Own STAAR Surgical.
Don't just ask, "How much inventory?" Ask, "What kind?"STAAR Surgical Company CEO Presents at ASCRS Symposium on Cataract and Refractive Surgery (Transcrip
STAAR Surgical Company CEO Presents at ASCRS Symposium on Cataract and Refractive Surgery (Transcript)STAA's Top Competitors
(10.98%)
(0.21%)
(-0.50%)